People: Omeros Corp (OMER.OQ)

OMER.OQ on NASDAQ Stock Exchange Global Market

22.59USD
22 Dec 2014
Price Change (% chg)

$-0.54 (-2.33%)
Prev Close
$23.13
Open
$23.02
Day's High
$23.47
Day's Low
$22.41
Volume
112,643
Avg. Vol
132,581
52-wk High
$23.62
52-wk Low
$9.80

Search Stocks

Demopulos, Gregory 

Brief Biography

Dr. Gregory A. Demopulos, M.D., is Chairman of the Board, President, Chief Executive Officer of Omeros Corp. He is one of founders and has served as president, chief executive officer and chairman of the board of directors since June 1994 and, in an interim capacity, as chief financial officer and treasurer since January 2009. He also served as chief medical officer from June 1994 to March 2010. Prior to founding Omeros, Dr. Demopulos completed his residency in orthopedic surgery at Stanford University and his fellowship training at Duke University. Dr. Demopulos currently serves on the board of directors of Onconome, Inc., a privately held company developing biomarkers for early cancer detection. Dr. Demopulos received his M.D. from the Stanford University School of Medicine and his B.S. from Stanford University.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
664,625 -- 2,586,360 3,250,980

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 10,000 103,100.00
Name Fiscal Year Total

Gregory Demopulos

3,250,980

Michael Jacobsen

787,233

Marcia Kelbon

1,045,140

Thomas Cable

--

Peter Demopulos

--

Ray Aspiri

--
As Of 30 Dec 2013
Search Stocks